Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2005
11/09/2005EP1593683A2 Dihydro-2,3-Benzodiazepine derivatives
11/09/2005EP1592686A1 Gyrase inhibitors and uses thereof
11/09/2005EP1592673A2 Novel substituted 2,3-benzodiazepine derivatives
11/09/2005EP1419163B9 Tricyclic imidazopyridines
11/09/2005EP1320611B1 Heterologous production of polyketides
11/09/2005EP1307196A4 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP1019389B1 Epothilone derivatives
11/09/2005EP0918775B1 Phenyl-substituted cyclic ketoenol
11/09/2005CN1694979A Process for electrochemical oxidation of ferrocyanide to ferricyanide
11/08/2005US6962939 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/08/2005US6962920 6-aminofuro(2,3-d)pyrimidines and 6-aminopyrrolo(2,3-d) pyrimidines useful in treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii
11/08/2005US6962917 E.g., (R)-2-(4-((4-fluoro-1H-benzimidazol-2-ylmethyl)-amino)-piperidin-1-yl)-1-(6- methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/03/2005WO2005103683A1 Quantitative method of determining beryllium or a compound thereof in a sample
11/03/2005WO2005103057A1 6,7-dihydroxy-8-phenyl-3,6,7,8-tetrahydro-chromeno[7, 8-d]imidazole derivatives and their use as gastric acid secretion inhibitors
11/03/2005WO2005103051A1 Inhibitors of the hiv integrase enzyme
11/03/2005WO2005103039A1 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102275A2 Galantamine salts, method of producing it and nasal composition thereof
11/03/2005WO2005102176A1 Xanthene dyes
11/03/2005WO2005046608A3 Novel compound, corresponding compositions, preparation and/or treatment methods
11/03/2005US20050245741 Novel tricyclic spiropiperidines or spiropyrrolidines
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245561 Anti-tumour polycyclic carboxamides
11/03/2005US20050245534 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245505 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
11/03/2005DE102004017435A1 Annellierte Chinolinderivate Fused quinoline derivatives
11/03/2005CA2564353A1 Galantamine salts, method of producing it and nasal composition thereof
11/03/2005CA2563759A1 6,7-dihydroxy-8-phenyl-3,6,7,8-tetrahydro-chromeno[7, 8-d]imidazole derivatives and their use as gastric acid secretion inhibitors
11/02/2005EP1591443A1 Pyrazole derivative
11/02/2005EP1283855B1 Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines
11/02/2005EP0907642B1 Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/02/2005CN1692113A Polysubstituted imidazopyridines as gastric secretion inhibitors
11/02/2005CN1692108A Pesticidal heterocycles
11/01/2005US6960608 Fused indazoles and indoles and their use for the treatment of glaucoma
11/01/2005US6960593 6,7-dihydro-5H-pyrazolo[1,2a]pyrazol-1-ones which control inflammatory cytokines
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960474 Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
10/2005
10/27/2005WO2005100581A1 Novel isochroman compound and use thereof in anticancer agent, etc.
10/27/2005WO2005100366A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase
10/27/2005WO2005100362A1 Liquid external preparation containing pranoprofen
10/27/2005WO2005100355A1 Cyclic amine compound
10/27/2005WO2005100351A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR
10/27/2005WO2005100347A1 Methods for minimizing thioamide impurities
10/27/2005WO2005100346A1 Thioamide derivatives as progesterone receptor modulators
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005099702A2 R(-)-11-hydroxyaporphine derivatives and uses thereof
10/27/2005WO2005099687A2 Analogs of salinosporamide a
10/27/2005WO2005021515B1 Inhibitors of phosphodiesterase type-iv
10/27/2005WO2005007103A3 Use of parthenolide derivatives as antileukemic and cytotoxic agents
10/27/2005WO2004002490A3 Piperidine compounds as antibacterials
10/27/2005US20050239866 Fermentation product of marine actinomyces; antiproliferative agents; anticancer agents
10/27/2005US20050239863 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
10/27/2005US20050239812 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
10/27/2005US20050239810 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
10/27/2005US20050239806 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
10/27/2005US20050239804 Method for improved chemical synthesis of guanidinium alkaloids
10/27/2005US20050239794 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
10/27/2005US20050239793 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
10/27/2005US20050239782 Arylindenopyridines and related therapeutic and prophylactic methods
10/27/2005US20050239767 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands
10/27/2005US20050239752 Indole compounds useful for the treatment of cancer
10/27/2005US20050239178 Labeling of rapamycin using rapamycin-specific methylases
10/27/2005US20050239107 Trapped photochromes and thermochromes and uses for chromogenic detection, including detection of airborne contaminants
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005CA2564811A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase
10/27/2005CA2563010A1 Novel 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydroisoindol-1-one/5,6-dihydro-furo[2,3-c]pyrrol-4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor
10/27/2005CA2562465A1 R(-)-11-hydroxyaporphine derivatives and uses thereof
10/27/2005CA2562406A1 Cyclic amine compound
10/27/2005CA2561014A1 Thioamide derivatives as progesterone receptor modulators
10/26/2005EP1589089A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same
10/26/2005EP1589017A2 12,13-modified epothilone derivatives
10/26/2005EP1587810A1 Novel substituted 1,4]benzodioxino 2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
10/26/2005EP1587807A2 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/26/2005EP1587804A1 Androgen receptor antagonists
10/26/2005EP1587796A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands
10/26/2005EP1587786A1 2.4-DIHALOGEN-6-(C sb 2 /sb -C sb 3 /sb -ALKYL)-PHENYL SUBSTITUTED TETRAMIC ACID DERIVATIVES
10/26/2005EP1587509A2 Androgen receptor antagonists
10/26/2005EP1427408A4 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005CN1688585A Antitumoral analogs of lamellarins
10/26/2005CN1688576A Thiophene compounds
10/26/2005CN1688527A Fused benzene derivative and use
10/25/2005US6958336 Anticancer agents; immunosuppressants; antiallergens; antiinflammatory agents
10/25/2005US6958330 useful as synthetic intermediates in the preparation of inhibitors of beta-amyloid peptide release described in U.S. patent application Ser. No. 08/996,422; 5-amino-7-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one for example
10/25/2005US6958328 5H-indeno(1,2-b)pyridine-3-carboxylic acid,4-phenyl-2-amino-5-oxo-, ethyl ester; adenosine receptor antagonists, phosphodiesterase inhibitors; neurodegenerative disorders, AIDS; antiinflammatory agent
10/20/2005WO2005097803A1 Novel water-soluble prodrug
10/20/2005WO2005097802A1 Annelated quinoline derivatives as pesticide
10/20/2005WO2005097107A2 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005US20050234234 Acylating a 42-hydroxy rapamycin with a lipase in the presence of an acyl donor of a vinyl ester, an isopropenyl ester or an anhydride in a suitable organic solvent
10/20/2005US20050234092 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/20/2005US20050234091 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]-4H-thieno[3,2-b]pyridin-7-one derivatives
10/20/2005US20050234086 Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
1 ... 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 ... 298